The US Food and Drug Administration (FDA) is warning healthcare providers about potential hazards from interactions between implanted programmable cerebrospinal fluid (CSF) shunts and hearing implants ...

A study of an investigational interatrial shunt for treating high-risk heart failure patients with reduced and preserved ejection fraction suggests the device has a high degree of safety and efficacy, ...

PHOENIX -- The functional and quality-of-life benefits of creating a left-to-right shunt in the interatrial septum to offload failing hearts held up over the midterm in a series of small feasibility ...

Placement of an atrial shunt device intended to reduce pulmonary capillary wedge pressure (PCWP) during exercise in patients with heart failure and preserved ejection fraction (HFpEF) does not reduce ...

ATLANTA -- Creating a left-to-right shunt in the interatrial septum to offload failing hearts was associated with improved quality of life and symptoms in a series of small feasibility studies. Peak ...

Transcatheter implants designed to alleviate high left atrial (LA) pressures — which, as a possible way to treat heart failure (HF) once seemed like a long shot — are emerging as new stars of heart ...

Please provide your email address to receive an email when new articles are posted on . ANAHEIM, Calif. — A transcatheter interatrial shunt device reduced pulmonary capillary wedge pressure during ...

Inter-atrial shunts—investigational devices that create a small pathway for blood to pass from the left to the right side of the heart in order to improve heart failure symptoms and outcomes—may be ...

Results from early clinical evaluation of the Alleviant System to treat heart failure patients with preserved and reduced ejection fraction (HFpEF and HFrEF) was presented today as late-breaking ...

Please provide your email address to receive an email when new articles are posted on . “Dyspnea due to left atrial pressure overload during exercise is a hallmark of heart failure with preserved or ...

A new study suggests that some patients with HFpEF may benefit from a novel, minimally invasive cardiac implant device called an atrial shunt. The study also offers new insight into the role exercise ...